Back to Market Feed

Product Information

METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $0.5290 per ML under NDC 00703450204. Its NADAC has been published 180 times since May 18, 2016.

FDA first approved this application on Nov 27, 1991. Its Orange Book therapeutic-equivalence code is AP.

The High Outlier badge above means this manufacturer's average price in the Metoclopramide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METOCLOPRAMIDE 10 MG/2 ML VIAL

Metoclopramide
$0.5290per ML
High Outlier

Strength

5 mg/mL

NDC

00703450204

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

7/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA073135

FDA Approved

11/27/1991

TE Code

AP

On Market Since

12/1/1991

Pharmacological Classes

Dopamine D2 Antagonists
Dopamine-2 Receptor Antagonist

Price Statistics

The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 180 times since May 18, 2016, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5290 per ML
All-time high$0.6016 (May 14, 2025)
All-time low$0.4971 (Jun 19, 2024)
52-week high$0.5732
52-week low$0.5178
Median price$0.5235
Average price$0.5377
Largest weekly change+18.7% (Sep 18, 2024)
Weeks tracked180
Tracking sinceMay 18, 2016

Price History

1W

0.0%

1M

+0.8%

3M

+1.0%

6M

+2.1%

1Y

-6.8%

3Y

+5.7%

5Y

+5.7%

All

+5.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metoclopramide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
00121057616•PAI Holdings LLC
$0.1273
per ML
METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
62135052647•Chartwell RX LLC
$0.1288
per ML
METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
64950034416•Genus Lifesciences Inc.
$0.1288
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409341401•Hospira Inc.
$0.5290
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409341411•Hospira Inc.
$0.5290
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409525515•Hospira Inc.
$0.5290
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409525525•Hospira Inc.
$0.5290
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
23155024041•Heritage Pharmaceuticals Inc.
$0.5290
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
83634077902•Avenacy Inc.
$0.5290
per ML

Frequently asked questions

What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Teva Parenteral Medicines, Inc., is $0.5290 per ML (NDC 00703450204), effective Aug 19, 2026.

How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has risen 5.7%. It has been tracked across 180 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?

Since May 18, 2016, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.4971 (Jun 19, 2024) to a high of $0.6016 (May 14, 2025), with a median of $0.5235 per ML.

Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of METOCLOPRAMIDE 10 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?

METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 00703450204) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.